Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Atara Biotherap (ATRA)

Atara Biotherap (ATRA)
6.89 +0.84 (+13.88%) 01/22/25 [NASDAQ]
5.80 x 100 7.94 x 100
Realtime by (Cboe BZX)
5.80 x 100 7.94 x 100
Realtime - - (-) -
News & Headlines for Wed, Jan 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Atara Stock Plunges To 3-Month Low After FDA Blocks Blood Cancer Drug: Retail's Buying The Dip

CEO Cokey Nguyen expressed confidence in resolving the issue, expecting resubmission and potential approval within six months of addressing the manufacturing compliance concerns.

VXF : 200.23 (-0.32%)
VTI : 300.60 (+0.49%)
ATRA : 6.89 (+13.88%)
Here's Why You Should Consider Buying Atara Biotherapeutics Stock

Atara Biotherapeutics ATRA is a nimble allogeneic T cell immunotherapy company with several near-term catalysts. This Zacks Rank #2 (Buy) company boasts a pipeline of differentiated therapies across a...

PBYI : 2.95 (-1.01%)
CSTL : 26.62 (-0.37%)
ATRA : 6.89 (+13.88%)
HALO : 55.28 (-1.18%)
Insider Sale: EVP of $ATRA (ATRA) Sells 1,000 Shares

Jill Henrich, the EVP of $ATRA ($ATRA), sold 1,000 shares of the company on 11-18-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.9% of their shares. Following...

ATRA : 6.89 (+13.88%)
Atara Biotherapeutics: Q3 Earnings Snapshot

Atara Biotherapeutics: Q3 Earnings Snapshot

ATRA : 6.89 (+13.88%)
Atara Biotherapeutics: Q2 Earnings Snapshot

Atara Biotherapeutics: Q2 Earnings Snapshot

ATRA : 6.89 (+13.88%)
1 Penny Stock Where You Can Spend Less And Earn More

This tiny stock could soar more than 400%, according to Wall Street.

ATRA : 6.89 (+13.88%)
$SPX : 6,086.37 (+0.61%)
Atara Biotherapeutics: Q1 Earnings Snapshot

Atara Biotherapeutics: Q1 Earnings Snapshot

ATRA : 6.89 (+13.88%)
Atara Biotherapeutics: Q4 Earnings Snapshot

Atara Biotherapeutics: Q4 Earnings Snapshot

ATRA : 6.89 (+13.88%)
Atara Biotherapeutics: Q3 Earnings Snapshot

Atara Biotherapeutics: Q3 Earnings Snapshot

ATRA : 6.89 (+13.88%)
Atara Biotherapeutics: Q2 Earnings Snapshot

Atara Biotherapeutics: Q2 Earnings Snapshot

ATRA : 6.89 (+13.88%)

Barchart Exclusives

BofA Predicts No Rate Cuts in 2025: 3 Dividend Stocks to Watch
With Bank of America predicting no Federal Reserve rate cuts in 2025, investors may turn to high-dividend stocks for stable income and potential growth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar